Vera EA, Fong FT, Rodríguez RLA, López AM

Language: Spanish
References: 9
Page:
PDF size: 521.45 Kb.

ABSTRACT

Sarcoidosis is a disorder that produces non-caseating granulomas in one or more organs and tissues and its etiology is unknown. The lungs and lymphatic system are the most affected, but it can manifest in any other organ.
We present a 73-year-old female patient, with a history of bronchial asthma and type II diabetes mellitus, who came for consultation because 5 years ago she began to present loss of muscle strength, tremors of intention and easy tiredness. The patient primary diagnosis was a primary myopathy and treated with vitamin therapy. For the last 3 years she has had skin lesions interpreted as a diabetic dermopathy. A year ago these lesions increased on the left leg and appeared on the right leg, back, arms and face, and also hypoacusis was observed. A skin biopsy was performed resulting in a sarcoidosis diagnosis. The case is presented due to the rarity of this disease in our environment and the importance of accurate diagnosis.

REFERENCES

1. Pila R. Sarcoidosis. La Habana: ECIMED; 2010.

2. Reynolds HY. Sarcoidosis: impact of other illness on the presentation and management ofmulti-organ disease. Lung. 2002 [acceso 12/01/2021];180(5):281-99. Disponible en:http://revfinlay.sld.cu

3. Weinberger SE. Sarcoidosis. En: Arend WP, Armitage JO, Clemmons DR, Drazen JM,Griggs RC, LaRusso. Cecil Medicine. 23th ed. Philadelphia: Saunders Elsevier; 2008. p. 931-2.

4. Baughman RP, Lower EE. Sarcoidosis. En: Fauci AS, Kasper DL, Longo DL, BraunwaldE, Hauser SL, Jameson JL, et al. Harrison´s Principles of Internal Medicine. 18 ed. NewYork: McGraw-Hill; 2013. p. 449-514.

5. Du Bois RM, Goh N, McGrath D, Cullinar P. Is there a role for microorganism inthepathogenesis of sarcoidosis? J Int Med. 2003;253(1):4-17. DOI:https://doi.org/10.1046/j.1365-2796.2003.01073.x

6. Díaz JA. Sarcoidosis pediátrica: Revisión. Mediciego. 2013 [acceso 12/01/2021];13Suppl1:10. Disponible en:http://bvs.sld.cu/revistas/mciego/vol13_supl1_07/revisiones/r5_v13_supl107.html

7. Iannuzzi M, Fontana JR. Sarcoidosis: clinical presentation, immunopathogenesis andtherapeutics. JAMA. 2011;305(4):391-9. DOI: https://doi.org/10.1001/jama.2011.10

8. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), theEuropean Respiratory Society (ERS) and the World Association of Sarcoidosis and OtherGranulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERSExecutive Committee, 1999. Am J Respir Crit Care Med. 1999;160(2):736-55. DOI:https://doi.org/10.1164/ajrccm.160.2.ats4-99

9. Pila R, Bestard A, Amador J, Boladeres C. Sarcoidosis: estudio de 30 pacientes. Rev CubaMed. 1986;25(11):1027-37.